About
Small Molecule
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (11)
Clinical Trials (19)
View allTotal Trials
19
As Lead Sponsor
15
As Collaborator
4
Total Enrollment
695
By Phase
PHASE1/PHASE2: 2PHASE2: 8PHASE4: 1PHASE3: 3NA: 1PHASE1: 2
By Status
COMPLETED: 10RECRUITING: 3ACTIVE_NOT_RECRUITING: 2UNKNOWN: 2TERMINATED: 1APPROVED_FOR_MARKETING: 1
Clinical Trials Pipeline18 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06053814Lead Sponsor
NS-050/NCNP-03 in Boys With DMD (Meteor50)
PHASE1/PHASE2Recruiting
20 participants
Started: Sep 18, 2024 · Completed: May 31, 2027
NCT05996003Lead Sponsor
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
PHASE2Recruiting
20 participants
Started: Feb 22, 2024 · Completed: Sep 11, 2026
NCT06046222Lead Sponsor
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
PHASE2Recruiting
45 participants
Started: Dec 20, 2023 · Completed: Jul 31, 2026
NCT04854096Lead Sponsor
Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
PHASE2Terminated
7 participants
Started: Jan 31, 2023 · Completed: May 16, 2024
NCT04956289Lead Sponsor
Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)
PHASE2Completed
20 participants
Started: Jul 1, 2021 · Completed: Jul 13, 2023
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...